USANA Health Sciences, Inc. (NYSE:USNA) Director Sells $14,830.00 in Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director John Turman Fleming sold 500 shares of USANA Health Sciences stock in a transaction dated Monday, June 9th. The shares were sold at an average price of $29.66, for a total value of $14,830.00. Following the completion of the transaction, the director now directly owns 4,200 shares in the company, valued at $124,572. This represents a 10.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

USANA Health Sciences Stock Performance

Shares of USNA traded up $0.82 during trading hours on Tuesday, hitting $30.63. 46,364 shares of the company were exchanged, compared to its average volume of 134,395. The company has a market cap of $570.33 million, a PE ratio of 10.82, a PEG ratio of 0.93 and a beta of 0.63. The firm’s 50 day moving average is $27.64 and its 200-day moving average is $31.29. USANA Health Sciences, Inc. has a 52 week low of $23.10 and a 52 week high of $48.85.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, April 22nd. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.03. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The firm had revenue of $249.54 million during the quarter, compared to the consensus estimate of $243.08 million. During the same quarter in the prior year, the company earned $0.86 EPS. As a group, equities analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Wall Street Zen upgraded USANA Health Sciences from a “hold” rating to a “buy” rating in a report on Thursday, May 22nd. Sidoti lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th. Finally, DA Davidson reduced their price target on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a research report on Thursday, February 27th.

Institutional Trading of USANA Health Sciences

Several hedge funds and other institutional investors have recently modified their holdings of the company. Pzena Investment Management LLC increased its position in shares of USANA Health Sciences by 0.7% in the first quarter. Pzena Investment Management LLC now owns 1,095,186 shares of the company’s stock valued at $29,537,000 after acquiring an additional 8,110 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of USANA Health Sciences by 7.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock worth $27,751,000 after acquiring an additional 55,059 shares during the period. Geode Capital Management LLC boosted its holdings in shares of USANA Health Sciences by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 301,949 shares of the company’s stock worth $10,839,000 after acquiring an additional 4,829 shares during the period. American Century Companies Inc. boosted its stake in shares of USANA Health Sciences by 9.2% in the first quarter. American Century Companies Inc. now owns 255,242 shares of the company’s stock valued at $6,884,000 after buying an additional 21,445 shares during the period. Finally, Jacobs Levy Equity Management Inc. boosted its stake in shares of USANA Health Sciences by 46.2% in the first quarter. Jacobs Levy Equity Management Inc. now owns 188,511 shares of the company’s stock valued at $5,084,000 after buying an additional 59,535 shares during the period. Institutional investors and hedge funds own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.